Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-Label, Randomized, Controlled, Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy Using Dosage Recommending Device

NCT02424500 is registered in ClinicalTrials.gov with Hygieia Research LLC as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02424500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-Label, Randomized, Controlled, Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy Using Dosage Recommending Device
Lead sponsor
Hygieia Research LLC
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
June 30, 2017
Enrollment
181 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.